Setting 52 Week High, Addus Homecare Corporation (Nasdaq:ADUS) Ends The Day At $67.10

Addus Homecare Corporation (Nasdaq:ADUS)

July 26th, 2018

Addus Homecare Corporation closed Thursday up 1.05%, a $0.70 increase to close on $67.10. Furthermore it hit a new 52 week high of $67.45. The stock continues to trade well at 117% of its 52 week low of $30.95. It’s expected that Addus Homecare Corporation will report earnings within the next couple of weeks.

ADUS outperformed the rest of the Healthcare sector which went down 0.20% today.

Expectations from 4 analysts indicates that Addus Homecare Corporation might decline somewhat (-7.38%), while Finbox has calculated (with medium uncertainty) a fair value price of $59.35.

Addus Homecare Corporation Info

Addus HomeCare Corporation provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company’s personal care services offer assistance with activities of daily living. Its services include assistance with bathing, grooming, oral care, assistance with feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services, as well as other activities of daily living. The company’s payor clients include federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. As of December 31, 2017, the company served consumers through 116 offices located in 24 states. Addus HomeCare Corporation was founded in 1979 and is based in Frisco, Texas.

All amounts in USD unless otherwise indicated

ADUS daily update
ADUS daily update

Media Gazelle Inc (MG), a Nevada Corporation, owns and operates the online brand US Tribune News. MG does not offer financial advise, and is not a registered broker/dealer/analyst/adviser, holds no investment licenses, and may not sell, offer to sell or offer to buy any security. MG’s market updates, news are not a solicitation or recommendation to buy, sell or hold securities. MG shall not be held liable for any investment losses you may incur by using the information provided, this includes you trading the stocks mentioned on our sites. We recommend you talk to a financial adviser before trading any securities or taking any action based upon information on this site. MG does not guarantee the accuracy of the article.